Reliance Life Sciences Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Dhirubhai Ambani Life Sciences Centre, R-282 Ttc Area of MIDC, Thane Belapur Road, Rabale,, Navi Mumbai, Maharashtra 400701, India (IND)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3009510975 · DUNS 650213072
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 5 drugs, 1 already in shortage. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2026-02-27
- NAIBioresearch Monitoring2022-04-15
- VAIDrug Quality Assurance2019-11-22
- VAIDrug Quality Assurance2018-10-16
- NAIBioresearch Monitoring2018-01-25
- VAIDrug Quality Assurance2017-12-13
- VAIDrug Quality Assurance2015-08-14
- OAIDrug Quality Assurance2013-08-23
Drugs this plant is listed as making
5 distinct drugs across 16 products name this site in their FDA label.
- Azacitidinein shortageSomerset Therapeutics LLC
- bortezomibWaverley Pharma Inc
- CapecitabineLifestar Pharma LLC
- LenalidomideAccord Healthcare Inc.
- Pemetrexed disodiumSomerset Therapeutics LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.